1. Home
  2. SLS vs GROV Comparison

SLS vs GROV Comparison

Compare SLS & GROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • GROV
  • Stock Information
  • Founded
  • SLS 2012
  • GROV 2016
  • Country
  • SLS United States
  • GROV United States
  • Employees
  • SLS N/A
  • GROV N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • GROV Package Goods/Cosmetics
  • Sector
  • SLS Health Care
  • GROV Consumer Discretionary
  • Exchange
  • SLS Nasdaq
  • GROV Nasdaq
  • Market Cap
  • SLS 70.1M
  • GROV 59.0M
  • IPO Year
  • SLS N/A
  • GROV N/A
  • Fundamental
  • Price
  • SLS $1.06
  • GROV $1.33
  • Analyst Decision
  • SLS
  • GROV Buy
  • Analyst Count
  • SLS 0
  • GROV 1
  • Target Price
  • SLS N/A
  • GROV $2.00
  • AVG Volume (30 Days)
  • SLS 1.4M
  • GROV 242.6K
  • Earning Date
  • SLS 11-13-2024
  • GROV 03-05-2025
  • Dividend Yield
  • SLS N/A
  • GROV N/A
  • EPS Growth
  • SLS N/A
  • GROV N/A
  • EPS
  • SLS N/A
  • GROV N/A
  • Revenue
  • SLS N/A
  • GROV $213,781,000.00
  • Revenue This Year
  • SLS N/A
  • GROV N/A
  • Revenue Next Year
  • SLS N/A
  • GROV $0.84
  • P/E Ratio
  • SLS N/A
  • GROV N/A
  • Revenue Growth
  • SLS N/A
  • GROV N/A
  • 52 Week Low
  • SLS $0.50
  • GROV $1.19
  • 52 Week High
  • SLS $1.72
  • GROV $2.44
  • Technical
  • Relative Strength Index (RSI)
  • SLS 55.79
  • GROV 44.41
  • Support Level
  • SLS $0.87
  • GROV $1.32
  • Resistance Level
  • SLS $1.01
  • GROV $1.95
  • Average True Range (ATR)
  • SLS 0.08
  • GROV 0.13
  • MACD
  • SLS 0.01
  • GROV -0.02
  • Stochastic Oscillator
  • SLS 73.08
  • GROV 6.06

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About GROV Grove Collaborative Holdings Inc.

Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products.

Share on Social Networks: